American National Bank & Trust (Virginia)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$285K Buy
+10,274
New +$285K 0.07% 120
2015
Q4
$1.78M Sell
58,125
-521
-0.9% -$16.4K 0.85% 49
2015
Q3
$1.75M Sell
58,646
-147
-0.3% -$4.71K 0.89% 47
2015
Q2
$1.87M Buy
58,793
+1,851
+3% +$60.3K 0.89% 44
2015
Q1
$1.88M Buy
56,942
+21
+0% +$668 0.88% 47
2014
Q4
$1.68M Buy
56,921
+5,119
+10% +$147K 0.8% 49
2014
Q3
$1.45M Buy
51,802
+3,540
+7% +$99.4K 0.71% 52
2014
Q2
$1.36M Buy
48,262
+630
+1% +$18K 0.69% 47
2014
Q1
$1.45M Sell
47,632
-772
-2% -$23K 0.74% 43
2013
Q4
$1.41M Sell
48,404
-1,704
-3% -$49.6K 0.71% 44
2013
Q3
$1.36M Sell
50,108
-3,549
-7% -$96.6K 0.74% 42
2013
Q2
$1.43M Buy
+53,657
New +$1.48M 0.79% 45

Other funds holding PFE

American National Bank & Trust (Virginia)'s PFE Position: Q1 2024 in Review

American National Bank & Trust (Virginia) opened a new position in Pfizer (PFE) in Q1 2024: 10,274 shares worth $285K. The stake represents 0.07% of the portfolio and ranks #120 among its holdings. This is a return to the name: American National Bank & Trust (Virginia) previously reported a position in PFE as recently as Q4 2015.

American National Bank & Trust (Virginia) first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.88M in Q1 2015. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • American National Bank & Trust (Virginia) held 10,274 shares of Pfizer worth $285K as of Q1 2024.
  • Pfizer was a new American National Bank & Trust (Virginia) position in Q1 2024.
  • Pfizer made up 0.07% of American National Bank & Trust (Virginia)'s portfolio in Q1 2024, its #120 holding.
  • American National Bank & Trust (Virginia) first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
  • American National Bank & Trust (Virginia)'s Pfizer position peaked at $1.88M in Q1 2015.
  • 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q1 2024, filed 19 Apr 2024.